Search

everythinglearnresearchcommunity

for

Search:↓

Some skin medications can have harmful interactions with the COVID-19 drug nirmatrelvir-ritonavir, but not with molnupiravir.

Passiflora incarnata may help with anxiety and sleep issues but has side effects; teleconsultation for heart failure can improve quality of life; increased screen time for children during the pandemic led to more clinical complaints; older and severely affected COVID-19 patients are more likely to have long-term symptoms.

Dilated scalp capillaries might be a sign of hair loss related to COVID-19.

Baricitinib is effective and safe for long-term use in severe alopecia areata, improving hair regrowth and quality of life with few side effects.

Hair loss may be a delayed side effect of Multisystem Inflammatory Syndrome in children after COVID-19.

Children's screen time increased during the pandemic, causing various health issues.

The pandemic worsened mental health and healthcare access for middle-aged women, leading to negative changes in their lifestyle.

Hair loss can indicate various health issues, including serious diseases, hormonal imbalances, and can significantly affect personal life and mental health.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

Pharmacists play a key role in managing the use of anxiety medications and ensuring patients use them correctly.

Plasma therapy is becoming more popular for treating viral infections, skin conditions, and orthopedic issues, and is expected to grow in the healthcare market.

The COVID-19 pandemic led to an increase in untreated hair diseases and showed the importance of teledermatology.

COVID-19 can cause various skin lesions, which may result from the virus and immune response, and are not directly linked to illness severity.

Androgenetic alopecia linked to COVID-19 severity; drugs reducing androgen receptor activation may help.

COVID-19 can cause various skin issues, including rashes and hair loss, which usually heal on their own and don't always indicate severe illness.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Non-Kuwaiti COVID-19 patients had worse health outcomes than Kuwaitis, likely due to poorer socioeconomic conditions.

Wait 3 months after COVID-19 before trying assisted reproduction and further research is needed on COVID-19's effects on male hormones and fertility.

Some COVID-19 patients have different skin problems, which might be the only sign of the virus or related to other health issues.

The treatment with an oral drug and topical lotion is effective and well-tolerated for hair loss after COVID-19.

The COVID-19 pandemic led to fewer dermatology visits, older and more male patients, and more stress-related skin issues.

Older adults in Vietnam often experience hair loss after COVID-19, especially women, singles, and those hospitalized.

COVID-19 can cause skin problems and affect dermatology treatments, with recommendations for skin care and cautious use of certain drugs.

COVID-19 can cause skin issues like "COVID toes," rashes, hair loss, and hand eczema, and dermatologists are important for recognizing these signs.

Use telemedicine and strict hygiene for safe hair and scalp treatments during COVID-19.

Men are more likely to have severe COVID-19 cases and fatalities than women due to factors like lifestyle, aging, and biological differences.

People with diabetes or obesity should manage their conditions carefully as they have a higher risk of severe COVID-19.

The conclusion is that individual differences in COVID-19 severity are influenced by factors like age, sex, race, and genetics, which are important for personalized medicine.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.